Back to Companies
AN2 Therapeutics, Inc.
ANTXNasdaqCIK: 0001880438
Over the 48 most recent insider filings, AN2 Therapeutics, Inc. (ANTX) has seen activity from 14 distinct insiders — all of them on the sell side. The activity is heavily weighted toward selling: $0 bought versus $80.1K sold, net sales of $80.1K. Easom Eric is the most active by dollar volume, and the single largest transaction was $8.7M by Easom Eric. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$21.0M
Purchases
$0
Sales
$80.1K
Unique Insiders
14
Recent Insider Trades
48 loaded
| Aug 14 | ANTX AN2 Therapeutics, Inc. | Zakrzewski Joseph S | Insider | Gift | $0 |
| Jul 10 | ANTX AN2 Therapeutics, Inc. | Marks Gilbert Lynn | Insider | Grant | $0 |
| Jul 10 | ANTX AN2 Therapeutics, Inc. | Martin Patricia A. | Insider | Grant | $0 |
| Jul 10 | ANTX AN2 Therapeutics, Inc. | Aziz Kabeer | Insider | Grant | $0 |
| Jul 10 | ANTX AN2 Therapeutics, Inc. | Eizen Joshua M | Insider | Sell | $24.8K |
| Jun 2 | ANTX AN2 Therapeutics, Inc. | Williams Sarah Joanne | Insider | Sell | $1.2K |
| Apr 10 | ANTX AN2 Therapeutics, Inc. | Aziz Kabeer | Insider | Grant | $0 |
| Apr 10 | ANTX AN2 Therapeutics, Inc. | Martin Patricia A. | Insider | Grant | $0 |
| Apr 10 | ANTX AN2 Therapeutics, Inc. | Marks Gilbert Lynn | Insider | Grant | $0 |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | Day Lucy | Insider | Award | $2.8M |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | Zakrzewski Joseph S | Insider | Award | $979.0K |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | Marks Gilbert Lynn | Insider | Award | $389.7K |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | Aziz Kabeer | Insider | Award | $498.4K |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | FitzPatrick Margaret M | Insider | Award | $528.5K |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | Readnour Robin Shane | Insider | Award | $498.4K |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | Wong Stephanie | Insider | Award | $484.3K |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | Chanda Sanjay | Insider | Award | $2.2M |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | Eizen Joshua M | Insider | Award | $2.4M |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | Spigelman Melvin K | Insider | Award | $477.1K |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | Easom Eric | Insider | Award | $8.7M |
| Mar 23 | ANTX AN2 Therapeutics, Inc. | Martin Patricia A. | Insider | Award | $484.3K |
| Mar 5 | ANTX AN2 Therapeutics, Inc. | Williams Sarah Joanne | Insider | Sell | $347 |
| Feb 23 | ANTX AN2 Therapeutics, Inc. | Wong Stephanie | Insider | Award | $21.2K |
| Feb 23 | ANTX AN2 Therapeutics, Inc. | Aziz Kabeer | Insider | Award | $21.2K |
| Feb 23 | ANTX AN2 Therapeutics, Inc. | FitzPatrick Margaret M | Insider | Award | $21.2K |
| Feb 23 | ANTX AN2 Therapeutics, Inc. | Readnour Robin Shane | Insider | Award | $21.2K |
| Feb 23 | ANTX AN2 Therapeutics, Inc. | Williams Sarah Joanne | Insider | Grant | $0 |
| Feb 23 | ANTX AN2 Therapeutics, Inc. | Day Lucy | Insider | Grant | $80.1K |
| Feb 23 | ANTX AN2 Therapeutics, Inc. | Zakrzewski Joseph S | Insider | Award | $21.2K |
| Feb 23 | ANTX AN2 Therapeutics, Inc. | Spigelman Melvin K | Insider | Award | $21.2K |
| Feb 23 | ANTX AN2 Therapeutics, Inc. | Eizen Joshua M | Insider | Grant | $104.0K |
| Feb 23 | ANTX AN2 Therapeutics, Inc. | Chanda Sanjay | Insider | Grant | $80.1K |
| Feb 3 | ANTX AN2 Therapeutics, Inc. | Williams Sarah Joanne | Insider | Other | $0 |
| Jan 14 | ANTX AN2 Therapeutics, Inc. | Aziz Kabeer | Insider | Grant | $0 |
| Jan 14 | ANTX AN2 Therapeutics, Inc. | Martin Patricia A. | Insider | Grant | $0 |
| Jan 14 | ANTX AN2 Therapeutics, Inc. | Marks Gilbert Lynn | Insider | Grant | $0 |
| Jan 7 | ANTX AN2 Therapeutics, Inc. | Chanda Sanjay | Insider | Sell | $9.3K |
| Jan 7 | ANTX AN2 Therapeutics, Inc. | Prior Stephen David | Insider | Sell | $6.5K |
| Jan 7 | ANTX AN2 Therapeutics, Inc. | Eizen Joshua M | Insider | Sell | $25.0K |
| Jan 7 | ANTX AN2 Therapeutics, Inc. | Day Lucy | Insider | Sell | $8.9K |
| Nov 6 | ANTX AN2 Therapeutics, Inc. | Eizen Joshua M | Insider | Sell | $3.2K |
| Nov 6 | ANTX AN2 Therapeutics, Inc. | Prior Stephen David | Insider | Sell | $872 |
| Oct 14 | ANTX AN2 Therapeutics, Inc. | Martin Patricia A. | Insider | Grant | $0 |
| Oct 14 | ANTX AN2 Therapeutics, Inc. | Aziz Kabeer | Insider | Grant | $0 |
| Oct 14 | ANTX AN2 Therapeutics, Inc. | Marks Gilbert Lynn | Insider | Grant | $0 |
| Jul 11 | ANTX AN2 Therapeutics, Inc. | Marks Gilbert Lynn | Insider | Grant | $0 |
| Jul 11 | ANTX AN2 Therapeutics, Inc. | Aziz Kabeer | Insider | Grant | $0 |
| Jul 11 | ANTX AN2 Therapeutics, Inc. | Martin Patricia A. | Insider | Grant | $0 |
48 filings